Finance

Lists
KAPA:NYSEAMERICAN
Kairos Pharma Ltd
$1.84
+10.84%
(+0.18) 1D
$1.93
+4.72% (+0.087)
After hours
Closed: Sep 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KAPA...
Open
$1.67
High
$1.91
Low
$1.66
Mkt. cap
6.23M
Avg. vol.
95.73K
Volume
306.73K
52-wk high
$14.77
52-wk low
$1.51
EPS
-$0.28
Shares outstanding
3.38M
No. of employees
3
Open
$1.67
High
$1.91
Low
$1.66
Mkt. cap
6.23M
Avg. vol.
95.73K
Volume
306.73K
52-wk high
$14.77
52-wk low
$1.51
EPS
-$0.28
Shares outstanding
3.38M
No. of employees
3
About Kairos Pharma Ltd
CEO-
Employees3
Founded2013
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
608.00K
538.00K
684.00K
619.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
827.00K
877.00K
1.01M
798.00K
Operating expense
1.44M
1.42M
1.69M
1.42M
Total operating expenses
1.44M
1.42M
1.69M
1.42M
Operating income
-1.44M
-1.42M
-1.69M
-1.42M
Other non operating income
-
-
-
-
EBT including unusual items
-1.40M
-1.36M
-1.65M
-1.39M
EBT excluding unusual items
-1.40M
-1.36M
-1.65M
-1.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.40M
-1.36M
-1.65M
-1.39M
Net profit margin
-
-
-
-
Earnings per share
-0.49
-0.49
-0.56
-0.42
Interest and investment income
37.00K
50.00K
36.00K
29.00K
Interest expense
-
-
-
-
Net interest expenses
37.00K
50.00K
36.00K
29.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.40M
-1.38M
-1.65M
-1.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps